Philadelphia-Positive Myeloid Leukemia
2 clinical trials · Condition
◉ Watch Philadelphia-Positive Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib (NCT00101660) | Bristol-Myers Squibb | 2005-02-01 |
| Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia (NCT00103844) | Bristol-Myers Squibb | 2005-02-01 |
Track Philadelphia-Positive Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.